Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy

Clinical trial NCT06972615 · RECRUITING

Trial details

NCT number: NCT06972615
Sponsor: BLATAM
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Non Muscle Invasive Bladder Cancer

Start date: 2026-05-21
Primary completion: 2029-12-31
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.